400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / ROS / 氮氧自由基哌啶醇
CAS No.: 2226-96-2
Synonyms: 4-Hydroxy-TEMPO
Tempol is a superoxide scavenger that displays neuroprotective, anti-inflammatory and analgesic effects.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03312725 | - | - | Terminated(Sponsor decision) | - | Belgium ... more >> University Hospital Ghent Ghent, Belgium Collapse << |
NCT03680404 | Cardiovascular Diseases ... more >> Cardiovascular Risk Factor Vasoconstriction Collapse << | Phase 1 | Not yet recruiting | October 1, 2019 | United States, Texas ... more >> Engineering Research Building Not yet recruiting Arlington, Texas, United States, 76019 Contact: R. Matthew Brothers, PhD 8172723156 matthew.brothers@uta.edu Contact: John D Akins, MS 8172721835 john.akins@uta.edu Collapse << |
NCT03680638 | Cardiovascular Diseases ... more >> Cardiovascular Risk Factor Vasodilation Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> Engineering Research Building Arlington, Texas, United States, 76019 Collapse << |
实验方案
技术信息
CAS号 | 2226-96-2 | 储存条件 |
|
|||||||
分子式 | C9H18NO2 | 运输 | 蓝冰 | |||||||
分子量 | 172.24 | 别名 | 4-Hydroxy-TEMPO | |||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03312725 | - | - | Terminated(Sponsor decision) | - | Belgium ... more >> University Hospital Ghent Ghent, Belgium Collapse << |
NCT03680404 | Cardiovascular Diseases ... more >> Cardiovascular Risk Factor Vasoconstriction Collapse << | Phase 1 | Not yet recruiting | October 1, 2019 | United States, Texas ... more >> Engineering Research Building Not yet recruiting Arlington, Texas, United States, 76019 Contact: R. Matthew Brothers, PhD 8172723156 matthew.brothers@uta.edu Contact: John D Akins, MS 8172721835 john.akins@uta.edu Collapse << |
NCT03680638 | Cardiovascular Diseases ... more >> Cardiovascular Risk Factor Vasodilation Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> Engineering Research Building Arlington, Texas, United States, 76019 Collapse << |
NCT03376555 | Microvascular Dysfunction | Phase 1 Phase 2 | Recruiting | June 30, 2019 | United States, Pennsylvania ... more >> Pennsylvania State University Recruiting University Park, Pennsylvania, United States, 16802 Collapse << |
NCT02758431 | Hypogonadism | Not Applicable | Recruiting | January 2021 | United States, Colorado ... more >> University of Colorado CCTSI CTRC Recruiting Denver, Colorado, United States, 80045 Contact: Kerrie Moreau, PhD 303-724-1914 kerrie.moreau@ucdenver.edu Collapse << |
NCT00713154 | Alopecia | Phase 2 | Terminated(Major planned study... more >> protocol modifications) Collapse << | September 2008 | - |
NCT00801086 | Alopecia | Phase 2 | Unknown | June 2010 | United States, Arizona ... more >> University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Jamie Holt 520-694-6000 ext 2970 Principal Investigator: Baldassarre Stea, MD,PhD United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Deborah Smith, RN 215-662-6694 Principal Investigator: Jim Metz, MD Collapse << |
NCT01324141 | Anal Cancer | Phase 1 | Terminated | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT03480971 | Mucositis Nep... more >>hrotoxicity Ototoxicity Collapse << | Phase 2 | Not yet recruiting | October 2019 | United States, Maryland ... more >> University Maryland School of Medicine Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Robert Malyapa, MD 410-328-6080 Principal Investigator: Robert Malyapa, MD Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网